Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 30 Dec 2025 for Cogent Biosciences, Inc., €2.5M.
Filing timeline
BuySaleJohn L. Green
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
John L. Green: trading record in brief
John L. Green discloses dealings in Cogent Biosciences, Inc. to SEC (Form 4). The record holds 9 filings, for trades running from 6 July 2020 to 26 December 2025.
Every open-market trade on record is a sale: 2 sales worth €2.7M. Other entries cover 6 share grants and 1 option exercise. Since January 2025: no purchases and 1 sale on the market.
The newest entry dates from 30 December 2025: an open-market sale of €2.5M, in Cogent Biosciences, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John L. Green
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
77,000 shares@ US$38.68100.0% of flowCommon StockSEC:0001193125-25-337051:0
300,000 shares0Common StockSEC:0001193125-25-326771:1
145,007 shares@ US$39.4564.2% of flowCommon StockSEC:0001193125-25-326771:2
50,000 shares0Common StockSEC:0001193125-25-326771:0
17,813 shares@ US$8.864.8% of flowCommon StockSEC:0000899243-21-017261:0
524 shares0Common StockSEC:0000899243-21-008812:0
1,748 shares0Common StockSEC:0000899243-20-032853:0
31,873 shares@ US$2.202.4% of flowCommon StockSEC:0001209191-20-041824:1
109,459 sharesCommon StockSEC:0001209191-20-041824:0
9 of 9 declarations
